---
schema_version: "secwatch.filing_event.v1"
accession: "0001099800-24-000031"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T07:35:28.942766+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Edwards Lifesciences Chairman Michael Mussallem to Retire, Nicholas Valeriani to Succeed

## Summary
- Michael A. Mussallem will retire as Non-Executive Chairman and director effective May 7, 2024, the date of the annual meeting.
- Nicholas J. Valeriani, an independent director, is expected to be appointed as Chairman of the Board.
- Martha H. Marsh will not stand for re-election due to reaching retirement age under company guidelines.
- The changes were announced on March 26, 2024, in an 8-K filing by Edwards Lifesciences (NYSE: EW).

## SEC filing metadata
- accession: 0001099800-24-000031
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000031/0001099800-24-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000031/ew-20240326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001099800-24-000031
- JSON: https://secwatch.observer/filing/0001099800-24-000031.json
- Plain text: https://secwatch.observer/filing/0001099800-24-000031.txt

## Key facts
- Executive change
  Michael A. Mussallem departed as Non-Executive Chairman at Edwards Lifesciences Corp.
  - Action: retire
  - Role: Non-Executive Chairman
  source text: Michael A. Mussallem informed the Board of Directors (the Board) of his decision to retire as Non-Executive Chairman and a director of the Board which will be effective in conjunction with the Company’s annual meeting of stockholders on May 7, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000031/0001099800-24-000031-index.htm
- Executive change
  Martha H. Marsh departed as director at Edwards Lifesciences Corp.
  - Action: will not stand for re-election
  - Role: director
  source text: Martha H. Marsh has reached the retirement age set forth in the Company’s Corporate Governance Guidelines and will therefore not be nominated to stand for election to the Board at the 2024 Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000031/0001099800-24-000031-index.htm
- Executive change
  Nicholas J. Valeriani was appointed as Chairman of the Board at Edwards Lifesciences Corp.
  - Action: appointed
  - Role: Chairman of the Board
  source text: The Company expects to appoint Nicholas J. Valeriani, an independent director, to succeed Mr. Mussallem as Chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000031/0001099800-24-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.